The company has several newer products with fast-growing sales, notably including migraine therapy Nurtec ODT and cancer drugs Adcetris and Padcev. Pfizer's pipeline features 32 programs in late ...

Dr. Coric successfully led Biohaven through the FDA approval and launch of Nurtec ODT for the treatment of migraine. Under his leadership, the company also filed an NDA for its second drug candidate, ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Vlad Coric, M.D. to the company’s Board of Directors, effective immediately.

They’ll ultimately prescribe the smallest dosage that provides the desired effect. The following table highlights the basics of ondansetron’s dosage. All doses are listed in milligrams (mg).

It comes as an oral tablet. An interaction occurs because ... Qulipta currently has no reports of interacting with Nurtec, better known as Nurtec ODT (rimegepant). Both Qulipta and Nurtec ODT ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Joe and Teresa Graedon answer letters from readers in ...

Broadcom is a Zack Rank #1 (Strong Buy) that is a powerhouse in the semiconductor and infrastructure software industries. As AI adoption accelerates and demand for high-speed connectivity surges ...

A suspension of pantoprazole 2 mg/mL was prepared by triturating 20 40-mg tablets of pantoprazole ... bottles with childresistant caps,d a 3.75-mL sample was removed from each bottle and analyzed ...

and made an $11.6 billion takeover bid for Biohaven and its migraine therapy Nurtec ODT (rimegepant).